BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32256828)

  • 1. RRM2 elicits the metastatic potential of breast cancer cells by regulating cell invasion, migration and VEGF expression via the PI3K/AKT signaling.
    Zhuang S; Li L; Zang Y; Li G; Wang F
    Oncol Lett; 2020 Apr; 19(4):3349-3355. PubMed ID: 32256828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion.
    Ye Y; Tang X; Sun Z; Chen S
    Oncotarget; 2016 Apr; 7(14):17854-69. PubMed ID: 26895380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells
    Pan HM; Lang WY; Yao LJ; Wang Y; Li XL
    World J Gastrointest Oncol; 2019 Aug; 11(8):622-633. PubMed ID: 31435463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway.
    Li S; Mai H; Zhu Y; Li G; Sun J; Li G; Liang B; Chen S
    Mol Ther Nucleic Acids; 2020 Sep; 21():278-289. PubMed ID: 32615527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
    Wang L; Shi H; Liu Y; Zhang W; Duan X; Li M; Shi X; Wang T
    Int J Oncol; 2019 Aug; 55(2):473-487. PubMed ID: 31173185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway.
    Ke K; Lou T
    Oncol Lett; 2017 Nov; 14(5):5994-6000. PubMed ID: 29113237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
    Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclopeptide RA-V inhibits cell adhesion and invasion in both estrogen receptor positive and negative breast cancer cells via PI3K/AKT and NF-κB signaling pathways.
    Leung HW; Wang Z; Yue GG; Zhao SM; Lee JK; Fung KP; Leung PC; Lau CB; Tan NH
    Biochim Biophys Acta; 2015 Aug; 1853(8):1827-40. PubMed ID: 25953046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Mobility Group Box 1 (HMGB1) Promotes Angiogenesis and Tumor Migration by Regulating Hypoxia-Inducible Factor 1 (HIF-1α) Expression via the Phosphatidylinositol 3-Kinase (PI3K)/AKT Signaling Pathway in Breast Cancer Cells.
    He H; Wang X; Chen J; Sun L; Sun H; Xie K
    Med Sci Monit; 2019 Apr; 25():2352-2360. PubMed ID: 30930461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells.
    Lin KL; Tsai PC; Hsieh CY; Chang LS; Lin SR
    Chem Biol Interact; 2011 Nov; 194(2-3):148-58. PubMed ID: 22033475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells.
    Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
    Cell Biochem Funct; 2014 Aug; 32(6):485-95. PubMed ID: 24964901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
    Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netrin-1 elicits metastatic potential of non-small cell lung carcinoma cell by enhancing cell invasion, migration and vasculogenic mimicry via EMT induction.
    Zhang X; Cui P; Ding B; Guo Y; Han K; Li J; Chen H; Zhang W
    Cancer Gene Ther; 2018 Feb; 25(1-2):18-26. PubMed ID: 29234153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.